The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance
J.A. Del Campo(Central Luzon State University), Manuel Romero‐Gómez(Instituto de Biomedicina de Sevilla)
Cited by 24
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789